April 16th, local time, Chile’s Ministry of Health announced the first study on the efficiency of Coronavirus vaccine in Kerrlaifu, developed by China’s Coronavirus.
The report points out that 14 days after receiving two doses of the vaccine, the effective rate of prevention of Coronavirus infection was 67%, the prevention rate of hospitalization was 85%, the prevention rate of severe cases was 89%, and the prevention rate of infection death was 80%.
The report concludes that in the case of the new corona pneumonia outbreak, the Kerrifo vaccine can effectively prevent new coronavirus infection and the deterioration of the disease, should continue the current vaccination program.
Chile’s Health Minister Paris expressed satisfaction with the effectiveness of the Chinese vaccine at a press conference, saying chile will continue to vaccinate Against Covid-19 without relaxing its pandemic prevention policy. In the future, Chile’s Ministry of Health will update monthly data on the effectiveness of the Coronavirus vaccine.
